# Comparision of Pharmacokinetics(PK) and Pharmacodynamics(PD) of Biocon Insulin R and Humulin® R

> **NCT04022317** · PHASE1 · COMPLETED · sponsor: **Biocon Limited** · enrollment: 42 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **BIOLOGICAL:** Biocon Insulin R
- **BIOLOGICAL:** Humulin®R

## Key facts

- **NCT ID:** NCT04022317
- **Lead sponsor:** Biocon Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-18
- **Primary completion:** 2019-09-15
- **Final completion:** 2019-09-20
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2021-07-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04022317

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04022317, "Comparision of Pharmacokinetics(PK) and Pharmacodynamics(PD) of Biocon Insulin R and Humulin® R". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04022317. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*